Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.

Angela T H KwanZiji GuoFelicia CebanGia Han LeSabrina WongKayla M TeopizTaeho Greg RheeRoger HoJoshua D Di VincenzoSebastian BadulescuShakila MeshkatBing CaoJoshua D RosenblatGiacomo d'AndreaDonovan A DevLee PhanMehala SubramaniapillaiRoger S McIntyre

Published in: Advances in therapy (2024)

NCT05047952 (ClinicalTrials.gov).

Keyphrases

depressive symptoms
coronavirus disease
sars cov
major depressive disorder
oxidative stress
social support
sleep quality
respiratory syndrome coronavirus
bipolar disorder